Blank Bio
RNA Intelligence for Precision Medicine
- Business Model
- B2B
- Website
- blank.bio
- Total Funding
- $7.2M
- Last Round
- $7.2M SeedMay 2026
- Rounds
- 1
About
Blank Bio is an RNA foundation model company focused on precision medicine and oncology R&D. In May 2026, it announced a seed financing round and strategic collaboration with PacBio to advance RNA foundation models for precision oncology applications, leveraging high-resolution RNA sequencing data and machine learning.
Summary
Blank Bio is an Artificial Intelligence company. It has raised $7.2M in total across 1 round, most recently a $7.2M Seed round in May 2026. Investors include Define Ventures, Alumni Ventures and Y Combinator Continuity Fund.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2026
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...